These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Wang C. Acta Radiol Suppl; 1998 Sep; 415():1-31. PubMed ID: 9571956 [Abstract] [Full Text] [Related]
7. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent]. Steudel A, Layer G, Kraheck H, Hartlapp J, Reiser M. Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550 [Abstract] [Full Text] [Related]
8. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. Hamm B, Vogl TJ, Branding G, Schnell B, Taupitz M, Wolf KJ, Lissner J. Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218 [Abstract] [Full Text] [Related]
11. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518 [Abstract] [Full Text] [Related]
12. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging. Gong J, Xu J, Zhou K, Shen K. Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113 [Abstract] [Full Text] [Related]
17. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation]. Dobritz M, Fellner FA, Baum U, Nömayr A, Lell M, Klein P, Papadopoulos T, Bautz W. Rofo; 2002 Jul; 174(7):893-7. PubMed ID: 12101481 [Abstract] [Full Text] [Related]
18. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Karabacakoğlu A, Adigüzel Y, Karaköse S, Kayaçetin E, Haykir R. Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248 [Abstract] [Full Text] [Related]
19. [Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients]. Kopp AF, Laniado M, Aicher KP, Grönewäller EF, Claussen CD. Rofo; 1992 Dec; 157(6):539-47. PubMed ID: 1457788 [Abstract] [Full Text] [Related]
20. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs. Jung G, Heindel W, Krahe T, Kugel H, Walter C, Fischbach R, Klaus H, Lackner K. Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]